Daiichi Sankyo (OTCMKTS:DSNKY) Reaches New 52-Week Low – Time to Sell?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) shares reached a new 52-week low on Tuesday . The stock traded as low as $20.25 and last traded at $20.49, with a volume of 86885 shares changing hands. The stock had previously closed at $20.92.

Analyst Ratings Changes

Separately, Zacks Research cut Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Trading Down 1.3%

The stock’s 50-day simple moving average is $22.20 and its two-hundred day simple moving average is $23.61. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The firm has a market capitalization of $37.92 billion and a P/E ratio of 18.89.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.